Cav2.3

1

Berecki G et al. Mechanism of direct Cav2.2 channel block by the κ-opioid receptor agonist U50488H.
Neuropharmacology, 2016 May 28 , 109 (49-58).

2

Berecki G et al. Voltage-Gated R-Type Calcium Channel Inhibition via Human μ-, δ-, and κ-opioid Receptors Is Voltage-Independently Mediated by Gβγ Protein Subunits.
Mol. Pharmacol., 2016 Jan , 89 (187-96).

3

Castro J et al. α-Conotoxin Vc1.1 inhibits human dorsal root ganglion neuroexcitability and mouse colonic nociception via GABAB receptors.
Gut, 2016 Feb 17 , ().

4

Ye F et al. The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases.
Toxins (Basel), 2016 , 8 ().

5

Bragança B et al. Ion Fluxes through KCa2 (SK) and Cav1 (L-type) Channels Contribute to Chronoselectivity of Adenosine A1 Receptor-Mediated Actions in Spontaneously Beating Rat Atria.
Front Pharmacol, 2016 , 7 (45).

6

Goedicke-Fritz S et al. Evidence for functional and dynamic microcompartmentation of Cav-1/TRPV4/K(Ca) in caveolae of endothelial cells.
Eur. J. Cell Biol., 2015 Jul-Sep , 94 (391-400).

7

Kumar D et al. Cacna1c (Cav1.2) Modulates Electroencephalographic Rhythm and Rapid Eye Movement Sleep Recovery.
Sleep, 2015 Sep , 38 (1371-80).

8

Park SJ et al. Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3.
Biochim. Biophys. Acta, 2015 Oct , 1848 (2092-100).

9

Siapich SA et al. Low concentrations of ethanol but not of dimethyl sulfoxide (DMSO) impair reciprocal retinal signal transduction.
Graefes Arch. Clin. Exp. Ophthalmol., 2015 Oct , 253 (1713-9).

10

Rousset M et al. Regulation of neuronal high-voltage activated Ca(V)2 Ca(2+) channels by the small GTPase RhoA.
Neuropharmacology, 2015 Oct , 97 (201-9).

11

Neumaier F et al. Voltage-gated calcium channels: Determinants of channel function and modulation by inorganic cations.
Prog. Neurobiol., 2015 Mar 25 , ().

12

Weiergräber M A scientific assessment of CaV2.3 voltage-gated Ca2+ channels in rodent sleep architecture.
Sleep, 2015 Mar , 38 (501-2).

13

Schneider T et al. Cav2.3 E-/R-type voltage-gated calcium channels modulate sleep in mice.
Sleep, 2015 Mar , 38 (499).

14

Long Y et al. Genome-wide association study identifies QTLs for EBV of backfat thickness and average daily gain in Duroc pigs.
Genetika, 2015 Mar , 51 (371-8).

15

Tompkins JD et al. Nickel suppresses the PACAP-induced increase in guinea pig cardiac neuron excitability.
Am. J. Physiol., Cell Physiol., 2015 Jun 1 , 308 (C857-66).

16

Dibué-Adjei M et al. In response: Cav2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo.
Epilepsia, 2015 Jul , 56 (1181).

17

Mishra RC et al. Inhibition of Myogenic Tone in Rat Cremaster and Cerebral Arteries by SKA-31, an Activator of Endothelial KCa2.3 and KCa3.1 Channels.
J. Cardiovasc. Pharmacol., 2015 Jul , 66 (118-27).

18

Padula AE et al. KCNN Genes that Encode Small-Conductance Ca2+-Activated K+ Channels Influence Alcohol and Drug Addiction.
Neuropsychopharmacology, 2015 Jul , 40 (1928-39).

19

Drobinskaya I et al. Diethyldithiocarbamate-mediated zinc ion chelation reveals role of Cav2.3 channels in glucagon secretion.
Biochim. Biophys. Acta, 2015 Jan 17 , 1853 (953-964).

20

Matolcsi M et al. A novel explanation for observed CaMKII dynamics in dendritic spines with added EGTA or BAPTA.
Biophys. J., 2015 Feb 17 , 108 (975-85).

21

Licon Y et al. Inhibition of CaV2.3 channels by NK1 receptors is sensitive to membrane cholesterol but insensitive to caveolin-1.
Pflugers Arch., 2015 Aug , 467 (1699-709).

22

Waeckel L et al. Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure.
Pflugers Arch., 2015 Apr , 467 (817-31).

23

Schneider T et al. R-Type Voltage-Gated Ca(2+) Channels in Cardiac and Neuronal Rhythmogenesis.
Curr Mol Pharmacol, 2015 , 8 (102-8).

24

Dallérac GM et al. Dysfunctional Dopaminergic Neurones in Mouse Models of Huntington's Disease: A Role for SK3 Channels.
Neurodegener Dis, 2015 , 15 (93-108).

25

Wang K et al. Apamin Boosting of Synaptic Potentials in CaV2.3 R-Type Ca2+ Channel Null Mice.
PLoS ONE, 2015 , 10 (e0139332).

26

Klint JK et al. Isolation, synthesis and characterization of ω-TRTX-Cc1a, a novel tarantula venom peptide that selectively targets L-type Cav channels.
Biochem. Pharmacol., 2014 May 15 , 89 (276-86).

27

Climent B et al. Effects of obesity on vascular potassium channels.
Curr Vasc Pharmacol, 2014 May , 12 (438-52).

28

Siwek ME et al. The CaV2.3 R-type voltage-gated Ca2+ channel in mouse sleep architecture.
Sleep, 2014 May , 37 (881-92).

29

Jan WC et al. Exploring the associations between genetic variants in genes encoding for subunits of calcium channel and subtypes of bipolar disorder.
J Affect Disord, 2014 Mar , 157 (80-6).

30

Coleman N et al. New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
Mol. Pharmacol., 2014 Jun 23 , ().

31

Ricoy UM et al. Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics.
J. Neurophysiol., 2014 Jun 15 , 111 (2404-13).

32

Kimm T et al. Inhibition of A-type potassium current by the peptide toxin SNX-482.
J. Neurosci., 2014 Jul 9 , 34 (9182-9).

33

Wang K et al. Distinct Ca2+ sources in dendritic spines of hippocampal CA1 neurons couple to SK and Kv4 channels.
Neuron, 2014 Jan 22 , 81 (379-87).

34

Satake S et al. Cav2.1 channels control multivesicular release by relying on their distance from exocytotic Ca2+ sensors at rat cerebellar granule cells.
J. Neurosci., 2014 Jan 22 , 34 (1462-74).

35

Zaman T et al. LMO4 is essential for paraventricular hypothalamic neuronal activity and calcium channel expression to prevent hyperphagia.
J. Neurosci., 2014 Jan 1 , 34 (140-8).

36

Qian X et al. Positive feedback regulation of agonist-stimulated endothelial Ca2+ dynamics by KCa3.1 channels in mouse mesenteric arteries.
Arterioscler. Thromb. Vasc. Biol., 2014 Jan , 34 (127-35).

37

Cohen R et al. Lipid modulation of calcium flux through CaV2.3 regulates acrosome exocytosis and fertilization.
Dev. Cell, 2014 Feb 10 , 28 (310-21).

38

Zhao LM et al. Advanced glycation end products impair K(Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries.
Pflugers Arch., 2014 Feb , 466 (307-17).

39

Berecki G et al. Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation.
J. Gen. Physiol., 2014 Apr , 143 (465-79).

40

Perez-Reyes E et al. Ins and outs of T-channel structure function.
Pflugers Arch., 2014 Apr , 466 (627-33).

41

Wandall-Frostholm C et al. Pulmonary hypertension in wild type mice and animals with genetic deficit in KCa2.3 and KCa3.1 channels.
PLoS ONE, 2014 , 9 (e97687).

42

Berrout J et al. Emerging role of the calcium-activated, small conductance, SK3 K+ channel in distal tubule function: regulation by TRPV4.
PLoS ONE, 2014 , 9 (e95149).

43

Tevoufouet EE et al. Cardiac functions of voltage-gated Ca(2+) channels: role of the pharmacoresistant type (E-/R-Type) in cardiac modulation and putative implication in sudden unexpected death in epilepsy (SUDEP).
Rev. Physiol. Biochem. Pharmacol., 2014 , 167 (115-39).

44

Janbein M et al. Evidence for the interaction of endophilin a3 with endogenous Kca2.3 channels in PC12 cells.
Cell. Physiol. Biochem., 2014 , 34 (474-90).

45

Siddiqui T et al. Expression and contributions of TRPM7 and KCa2.3/SK3 channels to the increased migration and invasion of microglia in anti-inflammatory activation states.
PLoS ONE, 2014 , 9 (e106087).

46

Cox RH et al. A naturally occurring truncated Cav1.2 α1-subunit inhibits Ca2+ current in A7r5 cells.
Am. J. Physiol., Cell Physiol., 2013 Oct 15 , 305 (C896-905).

47

Ramachandra R et al. Identification of CaV channel types expressed in muscle afferent neurons.
J. Neurophysiol., 2013 Oct , 110 (1535-43).

48

Rozanski GM et al. Low voltage-activated calcium channels gate transmitter release at the dorsal root ganglion sandwich synapse.
J. Physiol. (Lond.), 2013 Nov 15 , 591 (5575-83).

49

Liu BS et al. Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole.
J Neuroimmune Pharmacol, 2013 Mar , 8 (227-37).

50

Takai J et al. Laminar shear stress upregulates endothelial Ca2+-activated K+ channels KCa2.3 and KCa3.1 via a Ca2+/calmodulin-dependent protein kinase kinase/Akt/p300 cascade.
Am. J. Physiol. Heart Circ. Physiol., 2013 Jun 21 , ().

51

Ma X et al. Functional role of TRPV4-KCa2.3 signaling in vascular endothelial cells in normal and streptozotocin-induced diabetic rats.
Hypertension, 2013 Jul , 62 (134-9).

52

Wulff H et al. Endothelial small-conductance and intermediate-conductance KCa channels: an update on their pharmacology and usefulness as cardiovascular targets.
J. Cardiovasc. Pharmacol., 2013 Feb , 61 (102-12).

53

Sukumaran SV et al. TRPV4 channel activation leads to endothelium-dependent relaxation mediated by nitric oxide and endothelium-derived hyperpolarizing factor in rat pulmonary artery.
Pharmacol. Res., 2013 Dec , 78 (18-27).

54

Qian A et al. Role of voltage gated Ca2+ channels in rat visceral hypersensitivity change induced by 2,4,6-trinitrobenzene sulfonic acid.
Mol Pain, 2013 , 9 (15).

55

Oliván-Viguera A et al. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
PLoS ONE, 2013 , 8 (e58614).

56

Ferreira R et al. Selective activation of KCa3.1 and CRAC channels by P2Y2 receptors promotes Ca(2+) signaling, store refilling and migration of rat microglial cells.
PLoS ONE, 2013 , 8 (e62345).

57

Benton DC et al. The relationship between functional inhibition and binding for K(Ca)2 channel blockers.
PLoS ONE, 2013 , 8 (e73328).

58

Ide S et al. Association between genetic polymorphisms in Ca(v)2.3 (R-type) Ca2+ channels and fentanyl sensitivity in patients undergoing painful cosmetic surgery.
PLoS ONE, 2013 , 8 (e70694).

59

Brennan SC et al. Fetal calcium regulates branching morphogenesis in the developing human and mouse lung: involvement of voltage-gated calcium channels.
PLoS ONE, 2013 , 8 (e80294).

60

Shakeri B et al. A quartet of leucine residues in the guanylate kinase domain of CaVβ determines the plasma membrane density of the CaV2.3 channel.
J. Biol. Chem., 2012 Sep 21 , 287 (32835-47).

61

Müller R et al. Atropine-sensitive hippocampal θ oscillations are mediated by Cav2.3 R-type Ca²⁺ channels.
Neuroscience, 2012 Mar 15 , 205 (125-39).

62

Zhao M et al. Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy.
J. Clin. Invest., 2012 Jul 2 , 122 (2672-9).

63

Li CX et al. [Distribution diversity of integrins and calcium channels on major human and mouse host cells of Leptospira species].
Zhejiang Da Xue Xue Bao Yi Xue Ban, 2012 Jul , 41 (410-7).

64

Damkjaer M et al. Pharmacological activation of KCa3.1/KCa2.3 channels produces endothelial hyperpolarization and lowers blood pressure in conscious dogs.
Br. J. Pharmacol., 2012 Jan , 165 (223-34).

65

Trombetta M et al. CACNA1E variants affect beta cell function in patients with newly diagnosed type 2 diabetes. the Verona newly diagnosed type 2 diabetes study (VNDS) 3.
PLoS ONE, 2012 , 7 (e32755).

66

Gao Y et al. Dynamin- and Rab5-dependent endocytosis of a Ca2+ -activated K+ channel, KCa2.3.
PLoS ONE, 2012 , 7 (e44150).

67

Hasenau AL et al. Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels.
Acta Physiol (Oxf), 2011 Sep , 203 (117-26).

68

Cens T et al. Two sets of amino acids of the domain I of Cav2.3 Ca(2+) channels contribute to their high sensitivity to extracellular protons.
Pflugers Arch., 2011 Aug , 462 (303-14).

69

Zaman T et al. Cav2.3 channels are critical for oscillatory burst discharges in the reticular thalamus and absence epilepsy.
Neuron, 2011 Apr 14 , 70 (95-108).

70

Rijkers K et al. Polymorphisms in CACNA1E and Camk2d are associated with seizure susceptibility of Sprague-Dawley rats.
Epilepsy Res., 2010 Sep , 91 (28-34).

71

Köhler R et al. Endothelial dysfunction and blood pressure alterations in K+-channel transgenic mice.
Pflugers Arch., 2010 May , 459 (969-76).

72

Vick KA et al. In vivo pharmacological manipulation of small conductance Ca(2+)-activated K(+) channels influences motor behavior, object memory and fear conditioning.
Neuropharmacology, 2010 Mar , 58 (650-9).

73

Gao Y et al. Recycling of the Ca2+-activated K+ channel, KCa2.3, is dependent upon RME-1, Rab35/EPI64C, and an N-terminal domain.
J. Biol. Chem., 2010 Jun 4 , 285 (17938-53).

74

Potier M et al. Altered SK3/KCa2.3-mediated migration in adenomatous polyposis coli (Apc) mutated mouse colon epithelial cells.
Biochem. Biophys. Res. Commun., 2010 Jun 18 , 397 (42-7).

75

González-Gutiérrez G et al. Swapping the I-II intracellular linker between L-type CaV1.2 and R-type CaV2.3 high-voltage gated calcium channels exchanges activation attributes.
Channels (Austin), 2010 Jan , 4 (42-50).

76

Köhler R et al. Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.
Expert Opin. Ther. Targets, 2010 Feb , 14 (143-55).

77

Schlichter LC et al. The Ca2+ activated SK3 channel is expressed in microglia in the rat striatum and contributes to microglia-mediated neurotoxicity in vitro.
J Neuroinflammation, 2010 , 7 (4).

78

Sones WR et al. Inhibition of vascular calcium-gated chloride currents by blockers of KCa1.1, but not by modulators of KCa2.1 or KCa2.3 channels.
Br. J. Pharmacol., 2009 Sep , 158 (521-31).

79

Lewis BB et al. Cloning and characterization of voltage-gated calcium channel alpha1 subunits in Xenopus laevis during development.
Dev. Dyn., 2009 Nov , 238 (2891-902).

80

Wölfle SE et al. Prominent role of KCa3.1 in endothelium-derived hyperpolarizing factor-type dilations and conducted responses in the microcirculation in vivo.
Cardiovasc. Res., 2009 Jun 1 , 82 (476-83).

81

Grgic I et al. Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.
Br. J. Pharmacol., 2009 Jun , 157 (509-26).

82

Sankaranarayanan A et al. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Mol. Pharmacol., 2009 Feb , 75 (281-95).

83

Köhler R Single-nucleotide polymorphisms in vascular Ca(2+)-activated K (+)-channel genes and cardiovascular disease.
, 2009 Dec 31 , ().

84

Chantome A et al. KCa2.3 channel-dependent hyperpolarization increases melanoma cell motility.
Exp. Cell Res., 2009 Dec 10 , 315 (3620-30).

85

Nyholt DR et al. A high-density association screen of 155 ion transport genes for involvement with common migraine.
Hum. Mol. Genet., 2008 Nov 1 , 17 (3318-31).

86

Chung G et al. Modulation of CaV2.3 calcium channel currents by eugenol.
J. Dent. Res., 2008 Feb , 87 (137-41).

87

Gao Y et al. Role of S3 and S4 transmembrane domain charged amino acids in channel biogenesis and gating of KCa2.3 and KCa3.1.
J. Biol. Chem., 2008 Apr 4 , 283 (9049-59).

88

Salvador-Recatalà V et al. Atypical properties of a conventional calcium channel beta subunit from the platyhelminth Schistosoma mansoni.
BMC Physiol., 2008 , 8 (6).

89

Raybaud A et al. The role of distal S6 hydrophobic residues in the voltage-dependent gating of CaV2.3 channels.
J. Biol. Chem., 2007 Sep 21 , 282 (27944-52).

90

Weiergräber M et al. Hippocampal seizure resistance and reduced neuronal excitotoxicity in mice lacking the Cav2.3 E/R-type voltage-gated calcium channel.
J. Neurophysiol., 2007 May , 97 (3660-9).

91

Murakami M et al. Modified sympathetic regulation in N-type calcium channel null-mouse.
Biochem. Biophys. Res. Commun., 2007 Mar 23 , 354 (1016-20).

92

Matthews EA et al. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain.
Eur. J. Neurosci., 2007 Jun , 25 (3561-9).

93

Toro-Castillo C et al. Muscarinic modulation of Cav2.3 (R-type) calcium channels is antagonized by RGS3 and RGS3T.
Am. J. Physiol., Cell Physiol., 2007 Jan , 292 (C573-80).

94

Meza U et al. Neurokinin 1 receptors trigger overlapping stimulation and inhibition of CaV2.3 (R-type) calcium channels.
Mol. Pharmacol., 2007 Jan , 71 (284-93).

95

Kang HW et al. Histidine residues in the IS3-IS4 loop are critical for nickel-sensitive inhibition of the Cav2.3 calcium channel.
FEBS Lett., 2007 Dec 22 , 581 (5774-80).

96

Muller YL et al. Variants in the Ca V 2.3 (alpha 1E) subunit of voltage-activated Ca2+ channels are associated with insulin resistance and type 2 diabetes in Pima Indians.
Diabetes, 2007 Dec , 56 (3089-94).

97

Holmkvist J et al. Polymorphisms in the gene encoding the voltage-dependent Ca(2+) channel Ca (V)2.3 (CACNA1E) are associated with type 2 diabetes and impaired insulin secretion.
Diabetologia, 2007 Dec , 50 (2467-75).

98

Sun HS et al. Zn2+ sensitivity of high- and low-voltage activated calcium channels.
Biophys. J., 2007 Aug 15 , 93 (1175-83).

99

Wulff H et al. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.
Curr. Med. Chem., 2007 , 14 (1437-57).

100

Pollandt S et al. Cocaine withdrawal enhances long-term potentiation induced by corticotropin-releasing factor at central amygdala glutamatergic synapses via CRF, NMDA receptors and PKA.
Eur. J. Neurosci., 2006 Sep , 24 (1733-43).

101

Yang SN et al. The role of voltage-gated calcium channels in pancreatic beta-cell physiology and pathophysiology.
Endocr. Rev., 2006 Oct , 27 (621-76).

102

Vinet J et al. Expression pattern of voltage-dependent calcium channel subunits in hippocampal inhibitory neurons in mice.
Neuroscience, 2006 Nov 17 , 143 (189-212).

103

Kohlmeier KA et al. Transmitter modulation of spike-evoked calcium transients in arousal related neurons: muscarinic inhibition of SNX-482-sensitive calcium influx.
Eur. J. Neurosci., 2006 Mar , 23 (1151-62).

104

Osanai M et al. Altered cerebellar function in mice lacking CaV2.3 Ca2+ channel.
Biochem. Biophys. Res. Commun., 2006 Jun 9 , 344 (920-5).

105

Srivastava S et al. Phosphatidylinositol 3-phosphate indirectly activates KCa3.1 via 14 amino acids in the carboxy terminus of KCa3.1.
Mol. Biol. Cell, 2006 Jan , 17 (146-54).

106

Natrajan R et al. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
Clin. Cancer Res., 2006 Dec 15 , 12 (7284-93).

107

Pardo NE et al. Acetylcholine release at neuromuscular junctions of adult tottering mice is controlled by N-(cav2.2) and R-type (cav2.3) but not L-type (cav1.2) Ca2+ channels.
J. Pharmacol. Exp. Ther., 2006 Dec , 319 (1009-20).

108

Kaja S et al. Compensatory contribution of Cav2.3 channels to acetylcholine release at the neuromuscular junction of tottering mice.
J. Neurophysiol., 2006 Apr , 95 (2698-704).

109

Krieger A et al. The molecular chaperone hsp70 interacts with the cytosolic II-III loop of the Cav2.3 E-type voltage-gated Ca2+ channel.
Cell. Physiol. Biochem., 2006 , 17 (97-110).

110

Kamp MA et al. Presynaptic 'Ca2.3-containing' E-type Ca channels share dual roles during neurotransmitter release.
Eur. J. Neurosci., 2005 Mar , 21 (1617-25).

111

Berrou L et al. The C-terminal residues in the alpha-interacting domain (AID) helix anchor CaV beta subunit interaction and modulation of CaV2.3 channels.
J. Biol. Chem., 2005 Jan 7 , 280 (494-505).

112

Yang SN et al. Beta-cell CaV channel regulation in physiology and pathophysiology.
Am. J. Physiol. Endocrinol. Metab., 2005 Jan , 288 (E16-28).

113

Jing X et al. CaV2.3 calcium channels control second-phase insulin release.
J. Clin. Invest., 2005 Jan , 115 (146-54).

114

Yang SN et al. CaV2.3 channel and PKClambda: new players in insulin secretion.
J. Clin. Invest., 2005 Jan , 115 (16-20).

115

Larsen JK et al. Disruption of growth hormone secretion alters Ca2+ current density and expression of Ca2+ channel and insulin-like growth factor genes in rat atria.
Am. J. Physiol. Heart Circ. Physiol., 2005 Feb , 288 (H829-38).

116

Granados-Gonzalez G et al. Identification of voltage-dependent Ca2+ channels in sea urchin sperm.
FEBS Lett., 2005 Dec 5 , 579 (6667-72).

117

Tuteja D et al. Differential expression of small-conductance Ca2+-activated K+ channels SK1, SK2, and SK3 in mouse atrial and ventricular myocytes.
Am. J. Physiol. Heart Circ. Physiol., 2005 Dec , 289 (H2714-23).

118

Layton MG et al. Cellular localization of voltage-gated calcium channels and synaptic vesicle-associated proteins in the guinea pig cochlea.
J. Mol. Neurosci., 2005 , 27 (225-44).

119

Dafi O et al. Negatively charged residues in the N-terminal of the AID helix confer slow voltage dependent inactivation gating to CaV1.2.
Biophys. J., 2004 Nov , 87 (3181-92).

120

Klöckner U et al. The cytosolic II-III loop of Cav2.3 provides an essential determinant for the phorbol ester-mediated stimulation of E-type Ca2+ channel activity.
Eur. J. Neurosci., 2004 May , 19 (2659-68).

121

D'Ascenzo M et al. Electrophysiological and molecular evidence of L-(Cav1), N- (Cav2.2), and R- (Cav2.3) type Ca2+ channels in rat cortical astrocytes.
Glia, 2004 Mar , 45 (354-63).

122

Bannister RA et al. Differential modulation of CaV2.3 Ca2+ channels by Galphaq/11-coupled muscarinic receptors.
Mol. Pharmacol., 2004 Feb , 65 (381-8).

123

Yokoyama K et al. Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance.
Eur. J. Neurosci., 2004 Dec , 20 (3516-9).

124

Lu ZJ et al. Arrhythmia in isolated prenatal hearts after ablation of the Cav2.3 (alpha1E) subunit of voltage-gated Ca2+ channels.
Cell. Physiol. Biochem., 2004 , 14 (11-22).

125

Liang H et al. Unified mechanisms of Ca2+ regulation across the Ca2+ channel family.
Neuron, 2003 Sep 11 , 39 (951-60).

126

Hajela RK et al. Comparative effects of methylmercury and Hg(2+) on human neuronal N- and R-type high-voltage activated calcium channels transiently expressed in human embryonic kidney 293 cells.
J. Pharmacol. Exp. Ther., 2003 Sep , 306 (1129-36).

127

Waka N et al. Localization of the calcium channel subunits Cav1.2 (alpha1C) and Cav2.3 (alpha1E) in the mouse organ of Corti.
Histol. Histopathol., 2003 Oct , 18 (1115-23).

128

Kohn AB et al. Specific sites in the Beta Interaction Domain of a schistosome Ca2+ channel beta subunit are key to its role in sensitivity to the anti-schistosomal drug praziquantel.
Parasitology, 2003 Oct , 127 (349-56).

129

Cohen R et al. The C2A domain of synaptotagmin alters the kinetics of voltage-gated Ca2+ channels Ca(v)1.2 (Lc-type) and Ca(v)2.3 (R-type).
J. Biol. Chem., 2003 Mar 14 , 278 (9258-66).

130

Dietrich D et al. Functional specialization of presynaptic Cav2.3 Ca2+ channels.
Neuron, 2003 Jul 31 , 39 (483-96).

131

Takei T et al. Anesthetic sensitivities to propofol and halothane in mice lacking the R-type (Cav2.3) Ca2+ channel.
Anesth. Analg., 2003 Jul , 97 (96-103, table of contents).

132

Carlson AE et al. CatSper1 required for evoked Ca2+ entry and control of flagellar function in sperm.
Proc. Natl. Acad. Sci. U.S.A., 2003 Dec 9 , 100 (14864-8).

133

Leroy J et al. Ca2+-sensitive regulation of E-type Ca2+ channel activity depends on an arginine-rich region in the cytosolic II-III loop.
Eur. J. Neurosci., 2003 Aug , 18 (841-55).

134

Bergquist F et al. Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis.
Neuroscience, 2003 , 120 (757-64).

135

Stephens GJ et al. The Cav2.1/alpha1A (P/Q-type) voltage-dependent calcium channel mediates inhibitory neurotransmission onto mouse cerebellar Purkinje cells.
Eur. J. Neurosci., 2001 May , 13 (1902-12).

136

Joux N et al. High voltage-activated Ca2+ currents in rat supraoptic neurones: biophysical properties and expression of the various channel alpha1 subunits.
J. Neuroendocrinol., 2001 Jul , 13 (638-49).

137

Berrou L et al. Molecular determinants of inactivation within the I-II linker of alpha1E (CaV2.3) calcium channels.
Biophys. J., 2001 Jan , 80 (215-28).

138

Wennemuth G et al. CaV2.2 and CaV2.3 (N- and R-type) Ca2+ channels in depolarization-evoked entry of Ca2+ into mouse sperm.
J. Biol. Chem., 2000 Jul 14 , 275 (21210-7).